Concepedia

Publication | Open Access

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

DOIFull Paper Access

106

Citations

44

References

2018

Year

Ana-María Lacosta, María Pascual‐Lucas, Pedro Pesini, Diego Casabona, Virginia Pérez‐Grijalba, Iván Marcos‐Campos, Leticia Sarasa, Jesús Canudas, Hassnae Badi, Inmaculada Monleón,
Alzheimer s Research & Therapy

Abstract

ClinicalTrials.gov, NCT03113812 . Retrospectively registered on 14 April 2017.

References

YearCitations

Page 1